Endocrine Disorders, Hypertension, Hypercholesterolemia, Acquired Heart Disease, and Cardiovascular Disease Flashcards
prevalence of DM in USA
8%
leading cause of new cases of blindness in American adults 20-74 years
DM
which hormone(s) decrease and increase blood glucose, respectively?
decrease: insulin
increase: glucagon, cortisol, adrenocorticotropin, epinephrine, thyroxine, somatotropin
what accounts for the decreased insulin sensitivity in type II diabetes?
decrease in the number of insulin receptors
Diagnostic criteria for T2DM
Any 1 of the following criteria met on two separate days:
- HbA1c greater than or equal to 6.5%
- FPG greater than or equal to 126 mg/dL
- 2-hour plasma glucose level greater than or equal to 200 mg/dL after 75 g OGT test
- random plasma glucose greater than or equal to 200 mg/dL in a patient with classic symptoms (polyphagia, polydipsia, polyuria)
% of patients w/ T1DM that present after 35 years of age?
25%
mechanism of T1DM
destruction of insulin-producing pancreatic beta cells, usually autoimmune
screening recommendations for patients with no risk factors or suggestive signs or symptoms of diabetes?
start at 45, then every 3 years if still normal
percentage of DM in USA that is type II?
90%
percentage of T2DM patients wit obesity?
80-90
non obesity risk factors for T2DM?
hypertension, gestational diabetes, physical inactivity, low socioeconomic status
prevalence of gestational diabetes in USA? percentage of patients with gestational DM who develop T2DM by 10 years?
4% of all pregnancies in USA
30-50%
criteria for impaired glucose tolerance, impaired fasting glucose, and pre-diabetes by HbA1c?
FG: >/=110
IGT: >/=140
A1c >/= 5.7 (or 6.0, depending on source…)
HbA1c goal for diabetic patients?
7.0
name the different types of insulin therapy with the specific drugs in each class. also state onset of action for each type
rapid-acting (15 min): aspart, glulisine, lispro regular/short acting (30 min): regular human insulin intermediate acting (2-4 hr): insulin isophane suspension long-acting (several hrs): glargine, detemir
what are the Somogyi phenomenon and the dawn phenomenon?
Somogyi: rebound hyperglycemia after episode of hypoglycemia (can make insulin self-dosing difficult)
dawn: early morning hyperglycemia, likely from growth hormone secreted during sleep
treatment of acute hypoglycemia?
sugary food/drink if able to swallow. otherwise, 25g iv glucose or 1mg subQ glucagon
after diet and exercise, what is the first line treatment for T2DM? MOA?
Metformin (biguanide). Unknown, but ultimately increases insulin sensitivity
what oral medication class has the greatest efficacy in glycemic lowering, and what is its MOA?
sulfonylureas. increase pancreatic insulin secretion
contraindications to sulfonylureas
pregnancy, and any history of prior ketoacidosis
most significant adverse effect of sulfonylureas?
hypoglycemia
common side effect of Metformin? more severe side effect?
GI upset. lactic acidosis
contraindications to Metformin? special precautions when taking Metformin?
Renal insufficiency.
Given risk of lactic acidosis, hold Metformin prior to receiving iodinated contrast and hold prior to surgery
mechanism and common side effect of alpha-glucosidase inhibitors?
delay absorption of carbohyrates. flatulence
mechanism and side effects of thiazolidinediones
increase insulin sensitivity and decrease hepatic gluconeogenesis. can cause fluid retention resulting in cardiovascular complications. also have increased rates of diabetic macular edema
mechanisms of GLP-1 agonists, DPP-IV inhibitors, and SGLT2 inhibitors
GLP-1 agonists act like incretins and therefore increase post-prandial insulin, decrease post-prandial glucagon and increase satiety. DPP-IV inhibitors decrease the breakdown of natural incretins.
SGLT2 inhibitors lower the threshold of urinary glucose excretion
main difference between nonketotic hyperglycemic hyperosmolar coma and DKA?
ketoacids are formed in DKA (glucose can not enter cells due to very little or no insulin, leading to a superimposed metabolic acidosis)
diagnostic cutoff for diabetic nephropathy?
albuminuria >/= 300 mg/24 h
describe the pathway for thyroid hormone action
TRH (hypothalamus) –> TSH (anterior pituitary) –> release of T4 and T3 from thyroid. T4 is de-iodinated in liver and kidneys. T3 is active form. 99.7% of T3 is rendered inactive by binding to TBG in blood. Remainder of active T3 regulates tissue metabolism including CNS development and bone growth. T3 and T4 negatively feed back on TSH.
screening recommendations for thyroid disease?
TSH and free T4
laboratory risk factors for TED in Graves?
high thyroid stimulating immunoglobulin and absence of thyroperoxidase antibody
T or F:
- Graves has a 10:1 female preponderance
- thyroid stimulating immunoglobulin levels correlate with the severity of clinical disease in Graves
- Peaks in 5th and 6th decade of life
- stress and cigarette smoking are risk factors
- T
- T
- F (3rd and 4th decade)
- T
proportion of Graves patients who have clinically obvious TED at time of diagnosis?
1/3
treatments for Graves. which treatment can worsen TED, and what can you co-administer to help ameliorate this?
B-blocker for symptoms, PTU or methimazole, radioactive iodine (I 131), partial thyroidectomy
Radioactive Iodine can worsen TED, but corticosteroids can help prevent this side effect